
The study presents the development and validation of the SPRAY PAL questionnaire, designed to evaluate the acceptability, feasibility, and tolerability of an intranasal Q-Griffithsin (Q-GRFT) drug for COVID-19 prophylaxis. It involved healthy volunteers in a phase 1 clinical trial and demonstrated the questionnaire's reliability in assessing patient-reported product acceptability and usability outcomes.
Like
Save
Share